STOCK TITAN

Nephros to Present at the Virtual Summer Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) announced its participation in the Virtual Summer Summit scheduled for June 9, 2020, at 10:55 AM ET. Andy Astor, the company's COO & CFO, will present and field questions from investors. Nephros specializes in high-performance water purification products and pathogen detection systems for medical and commercial markets, including hospitals and dialysis centers. Interested parties can access the webcast presentation and register for the event via Nephros's official links.

Positive
  • None.
Negative
  • None.

SOUTH ORANGE, N.J., June 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be presenting at the upcoming Virtual Summer Summit on Tuesday, June 9th at 10:55 AM ET. Andy Astor, COO & CFO of Nephros, will be giving the presentation and answering questions from investors.

You can access the webcast presentation at the following link: HERE

For more information and to register to attend or request a 1/1 virtual call click: HERE  

About Nephros

Nephros is a commercial-stage company that develops and markets high performance water purification products and pathogen detection systems for medical and commercial markets.

Nephros ultrafilters are used in hospitals, medical clinics, and commercial facilities to retain bacteria and viruses from water, providing barriers that aid in infection control for showers, sinks, and ice machines. Nephros ultrafilters are also used in dialysis centers to aid in the removal of endotoxins and other biological contaminants from water and bicarbonate concentrate in hemodialysis machines. 

Nephros pathogen detection systems, including the PluraPath™ system, provide real-time data on waterborne bacteria and virus content to medical and water quality professionals. Our products integrate Nephros ultrafilters with quantitative polymerase chain reaction (qPCR) technology to deliver actionable water pathogen information within an hour.

Nephros commercial filters, including AETHER™ brand filters, improve the taste and odor of water, and reduce scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets.

For more information about Nephros, please visit its website at www.nephros.com

Contacts:

Investor Relations:
Kirin Smith, President
PCG Advisory, Inc.
(646) 863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com

Media Relations:
Bill Douglass
Gotham Communications, LLC
(646) 504-0890
bill@gothamcomm.com
www.gothamcomm.com

Company:
Andy Astor, COO & CFO
Nephros, Inc.
(201) 345-0824
andy@nephros.com
www.nephros.com


FAQ

When will Nephros present at the Virtual Summer Summit?

Nephros will present at the Virtual Summer Summit on June 9, 2020, at 10:55 AM ET.

Who will represent Nephros at the summit?

Andy Astor, COO & CFO of Nephros, will represent the company at the summit.

What products does Nephros offer?

Nephros develops high-performance water purification products and pathogen detection systems for medical and commercial markets.

How can I access the Nephros webcast presentation?

You can access the Nephros webcast presentation through the link provided in their press release.

What is the focus of Nephros's products?

Nephros's products focus on water purification and pathogen detection, particularly in healthcare settings.

Nephros Inc.

NASDAQ:NEPH

NEPH Rankings

NEPH Latest News

NEPH Stock Data

16.44M
9.24M
12.75%
40.93%
0.01%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
SOUTH ORANGE